Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.53 is 52% below its 5-year average of 11.60, near the low end of its 5-year range (4.42–29.60).
As of the fiscal period ended Tuesday, June 30, 2026. 0.06% below its 12-month average of 5.53.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.53.
QUICK RATIO (ACID-TEST)
5.53
QUICK RATIO (ACID-TEST) AVG TTM
5.53
QUICK RATIO (ACID-TEST) AVG 3Y
10.86
QUICK RATIO (ACID-TEST) AVG 5Y
11.60
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.06%
CURRENT VS 3Y AVG
-49.11%
CURRENT VS 5Y AVG
-52.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
+73.31%
vs the sector median at left
Annexon, Inc.
Market Cap
$677.49M
Quick Ratio (Acid-Test)
5.53
TTM Avg
5.53
3Y Avg
10.86
5Y Avg
11.60
Market Cap
$680.31M
Quick Ratio (Acid-Test)
10.97
TTM Avg
8.63
3Y Avg
10.75
5Y Avg
10.66
Market Cap
$670.70M
Quick Ratio (Acid-Test)
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$689.73M
Quick Ratio (Acid-Test)
14.20
TTM Avg
2.59
3Y Avg
2.42
5Y Avg
2.06
Market Cap
$669.77M
Quick Ratio (Acid-Test)
4.79
TTM Avg
3.80
3Y Avg
3.38
5Y Avg
3.21
Market Cap
$714.33M
Quick Ratio (Acid-Test)
8.86
TTM Avg
10.22
3Y Avg
11.35
5Y Avg
25.38
Market Cap
$637.17M
Quick Ratio (Acid-Test)
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$717.44M
Quick Ratio (Acid-Test)
0.84
TTM Avg
1.18
3Y Avg
1.08
5Y Avg
1.08
Market Cap
$720.94M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.81
3Y Avg
5.95
5Y Avg
7.14
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Annexon, Inc. (ANNX) | $677.49M | 5.53 | 5.53 | 10.86 | 11.60 |
| Helus Pharma Inc. (HELP)vs › | $680.31M | 10.97 | 8.63 | 10.75 | 10.66 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $670.70M | 8.03 | 12.16 | 13.50 | 14.42 |
| Anteris Technologies Global Corp. (AVR)vs › | $689.73M | 14.20 | 2.59 | 2.42 | 2.06 |
| MiMedx Group, Inc. (MDXG)vs › | $669.77M | 4.79 | 3.80 | 3.38 | 3.21 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $714.33M | 8.86 | 10.22 | 11.35 | 25.38 |
| Aura Biosciences, Inc. (AURA)vs › | $637.17M | 16.82 | 9.46 | 14.12 | 14.05 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $717.44M | 0.84 | 1.18 | 1.08 | 1.08 |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.94M | 3.86 | 4.81 | 5.95 | 7.14 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.59M | 19.31 | 14.05 | 7.67 | 5.91 |
Quick Ratio
5.53
Excludes inventory
Current Ratio
5.53
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.53 |
| 2026-03-31 | 6.35 |
| 2025-12-31 | 5.68 |
| 2025-09-30 | 4.42 |
| 2025-06-30 | 5.67 |
| 2025-03-31 | 7.99 |
| 2024-12-31 | 10.37 |
| 2024-09-30 | 17.18 |
| 2024-06-30 | 21.81 |
| 2024-03-31 | 20.62 |
| 2023-12-31 | 14.72 |
| 2023-09-30 | 9.85 |
| 2023-06-30 | 11.04 |
| 2023-03-31 | 10.14 |
| 2022-12-31 | 11.10 |
| 2022-09-30 | 13.59 |
| 2022-06-30 | 8.95 |
| 2022-03-31 | 12.39 |
| 2021-12-31 | 11.39 |
| 2021-09-30 | 23.11 |
| 2021-06-30 | 29.60 |
| 2021-03-31 | 30.90 |
| 2020-12-31 | 33.33 |
| 2020-09-30 | 41.56 |
| 2020-06-30 | 9.93 |
| 2020-03-31 | 5.45 |
| 2019-12-31 | 9.21 |
| 2019-09-30 | 10.68 |
| 2019-06-30 | 8.58 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 13.74 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
